Business Update

Company to divest capital equipment business; delays reporting Q2 earnings

Published in Biotech Business Week, August 22nd, 2005

Harvard Bioscience, Inc., (HBIO), announced that it plans to divest its capital equipment business and is in the final stages of engaging an investment bank to assist in this process.

Harvard Bioscience also reported its second quarter earnings release, originally scheduled for Thursday July 28, 2005, was postponed to August 8, 2005, after market close.

The postponement is to allow the company the necessary time to complete its review of whether or not the capital equipment business segment met the criteria for "held for sale" accounting treatment under Statement of Financial Accounting Standard (SFAS) No. 144, Accounting for the Impairment or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-08-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry